TH168423A - Nalmiphene salt as a drug for reducing alcohol consumption or for Preventing excessive alcohol consumption - Google Patents
Nalmiphene salt as a drug for reducing alcohol consumption or for Preventing excessive alcohol consumptionInfo
- Publication number
- TH168423A TH168423A TH1601000022A TH1601000022A TH168423A TH 168423 A TH168423 A TH 168423A TH 1601000022 A TH1601000022 A TH 1601000022A TH 1601000022 A TH1601000022 A TH 1601000022A TH 168423 A TH168423 A TH 168423A
- Authority
- TH
- Thailand
- Prior art keywords
- salt
- alcohol consumption
- nalmiphene
- hydrogen
- drug
- Prior art date
Links
- 239000011780 sodium chloride Substances 0.000 title claims abstract 17
- 150000003839 salts Chemical class 0.000 title claims abstract 16
- 239000003814 drug Substances 0.000 title claims abstract 3
- 229940079593 drugs Drugs 0.000 title claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 2
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 3
- 239000001257 hydrogen Substances 0.000 claims abstract 3
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-M adipate(1-) Chemical class OC(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-M 0.000 abstract 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical class [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 abstract 1
- -1 fumarate hydrogen salt Chemical class 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003893 lactate salts Chemical class 0.000 abstract 1
- OFOBLEOULBTSOW-UHFFFAOYSA-M malonate(1-) Chemical class OC(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-M 0.000 abstract 1
- 150000003873 salicylate salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-M succinate(1-) Chemical class OC(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-M 0.000 abstract 1
- 230000001225 therapeutic Effects 0.000 abstract 1
Abstract
การประดิษฐ์นี้เกี่ยวข้องกับเกลือของนาลมีฟีนชนิดใหม่ซึ่งเกลือจัดอยู่ในอย่างน้อยหนึ่งใน สองประเภทต่อไปนี้ เกลือที่ไม่ก่อรูปไฮเดรตและเกลือที่ไม่ก่อรูปโซลเวต โดยเฉพาะอย่างยิ่งการ ประดิษฐ์เกี่ยวข้องกับเกลือไฮโดรเจนอะดิเพต, เกลือไฮโดรเจนมาโลเนต, เกลือแลคเตต, เกลือ ไฮโดรเจนฟูมาเรต, เกลือไฮโดรเจนซัคซิเนต, เกลือเบนซีนซัลโฟเนต, เกลือไฮโดรเจนมาลีเอตและ เกลือซาลิไซเลตของนาลมีฟีน การประดิษฐ์นี้ยังเกี่ยวข้องกับเกลือดังกล่าวสำหรับใช้ในการรักษาโรค: สิทธิบัตรยา The invention involved a new type of nalmiphene salt, which was in at least one of the The following two types Un-hydrated and non-solvate salts Especially the Invention relates to hydrogen adipate salt, hydrogen malonate salt, lactate salt, fumarate hydrogen salt, hydrogen succinate salt, benzene sulfonate salt, hydrogen malite salt and Salicylate salt of nalmiphene The invention also relates to that salt for therapeutic use: drug patents.
Claims (4)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH168423A true TH168423A (en) | 2017-09-28 |
| TH1601000022A TH1601000022A (en) | 2017-09-28 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500676A1 (en) | Pyrimidine fgfr4 inhibitors | |
| WO2016011390A8 (en) | Irak4 inhibiting agents | |
| BR112015019627A2 (en) | heterocyclic amides as kinase inhibitors | |
| RS54730B1 (en) | Inhibitors of beta-secretase | |
| BR112015004029A2 (en) | PROCESS FOR PREPARING TENELIGLIPTIN, A COMPOUND OR A SALT OR HYDRATE THEREOF | |
| BR112015020904A2 (en) | microorganisms and methods for the production of butadiene and related compounds by formate assimilation | |
| AR095727A1 (en) | PREPARATION OF PYRIMIDINE INTERMEDIARIES | |
| EP3404032A3 (en) | Process for making benzoxazepin compounds | |
| MX2017013880A (en) | Tetrahydronaphthyridinyl propionic acid derivatives and uses thereof. | |
| EA201591915A1 (en) | COMPOUNDS OF PHENOXYETHYL DIHYDRO-1H-IZOHINOLINA | |
| CL2016001095A1 (en) | Microporous zirconium silicate for the treatment of hyperkalemia. | |
| GT201500292A (en) | CRYSTALLINE FORMS OF TYROSINE KINASE INHIBITORS AND THEIR SALTS | |
| EA201691999A1 (en) | NEW SULPHONYLAMINOBENZAMIDE COMPOUNDS | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| BR112016021910A2 (en) | PROCESS FOR THE PREPARATION OF 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-IL)PYRIDIN-2-AMINE | |
| MX2016010564A (en) | Preparation of 3,4-dihydro-1,4-benzoxazepin-5(2h)-one derivatives by cyclisation of 2-(am i no ethyloxy) benzoic acid derivatives. | |
| TH168423A (en) | Nalmiphene salt as a drug for reducing alcohol consumption or for Preventing excessive alcohol consumption | |
| AR107163A1 (en) | QUINASE INHIBITORS | |
| CR20160165A (en) | ACUTATE OF 4- {4 - [(1 E) -4- (2,9- DIAZAESPIRO [5.5] UNDEC-2-IL) BUT-1 -EN-I -IL] -2- METILBENCIL} -5- (PROPAN -2-IL) -1H-PIRAZOL-3-ILO BETA-D- GLUCOPIRANOSIDE | |
| CR20170261A (en) | ACID 3- (6-ALCOXI-5-CLORBENZO [D] ISOXAZOL-3-IL) PROPANOIC USEFUL AS QUINURENINE MONOOXIGENASA INHUBERS | |
| EA201690593A1 (en) | NEW UREA COMPOUNDS | |
| BR112015028751A2 (en) | Process for the preparation of 3,5-bis (fluoralkyl) pyrazole derivatives from alpha, alpha-dihaloamines | |
| BR112015030589A2 (en) | polymorphic forms of icotinib phosphate and their uses | |
| PH12016500052B1 (en) | Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption | |
| MX2016005220A (en) | Acid dyes, process for the production thereof and their use. |